Hebert, Lee A <br/><br/>
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.  [electronic resource] 

 -  The New England journal of medicine  11 2010 
 - 2072-3; author reply 2073-4 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMc1009101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Cyclophosphamide--metabolism<br/>Humans<br/>Immunosuppressive Agents--metabolism<br/>Kidney Diseases--drug therapy<br/>Remission Induction<br/>Rituximab